Anumana vs Triomics
Triomics sells to cancer centers and Anumana to cardiology departments, so the two never meet in one evaluation.
Triomics' PRISM product screens upcoming patients against every active trial each night and gives coordinators a cited worklist, with matches arriving as in-basket messages. The vendor also offers visit preparation and cancer registry curation. It lists Epic, OncoEMR, iKnowMed and Cerner, and says it is approved on the Epic App Marketplace. Memorial Sloan Kettering announced a deployment in November 2025 and discloses institutional financial interests in the company. Triomics claims no FDA status, and the PRISM page labels some of its metrics as placeholders. A 2024 npj Digital Medicine paper describes the PRISM matching method, and the vendor cites about 95% accuracy.
Anumana takes XML or DICOM waveform files from a 12-lead ECG, says no PHI is exported for external processing, and has FDA clearances for low ejection fraction, pulmonary hypertension and cardiac amyloidosis.
Decision support · Reviewed November 2, 2026
When to pick each one
Anumana
- Cleared for low EF, PH and amyloidosis
- Vendor says no PHI is exported
Triomics
- Approved on the Epic App Marketplace
- Lives in Epic, OncoEMR and iKnowMed
Score
Each row shows points earned of points available under the published rubric.
Anumana
37of 100
Triomics
12of 100
| Dimension | Anumana | Triomics | Difference |
|---|---|---|---|
| FDA clearance | 12 / 12 | 0 / 12 | +12 |
| HIPAA / SOC2 / BAA | 0 / 10 | 0 / 10 | 0 |
| EHR integrations (count) | 0 / 5.6 | 2.8 / 5.6 | -2.8 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 4.8 | 3.4 / 4.8 | -3.4 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 14.7 / 21 | 0 / 21 | +14.7 |
| RCT / meta-analysis / systematic review | 0 / 9 | 0 / 9 | 0 |
| Funding & adoption signal | 3 / 12 | 3 / 12 | 0 |
| Pricing transparency | 1.3 / 2.5 | 1.3 / 2.5 | 0 |
| Years in market | 0 / 6 | 0 / 6 | 0 |
Scroll horizontally to see every column.
Pricing
Anumana
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. The pricing page returns 404; the site offers a demo request only. |
Triomics
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. Demo request and synthetic-data sandbox offered. |
Evidence
Anumana
FDA decisions
K253801 (opens in new tab)510(k)2026-04-07
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm (1040)
K252360 (opens in new tab)510(k)2026-03-28
ECG-AI Pulmonary Hypertension (PH) 12-Lead algorithm (1020)
K250652 (opens in new tab)510(k)2025-07-28
ECG-AI Low Ejection Fraction (LEF) 12-Lead algorithm (1010)
K232699 (opens in new tab)510(k)2023-09-28
Low Ejection Fraction AI-ECG Algorithm
Peer-reviewed
3 PubMed records name Anumana.
- A Pragmatic Trial Evaluating the Impact of the Anumana Clinical Decision Support Tool for Guideline-Directed Management of Heart Failure (ACT-HF): Clinical trial design and methods. (opens in new tab)
- Comment on "A pragmatic trial evaluating the impact of the anumana clinical decision support tool for guideline-directed management of heart failure (ACT-HF): Clinical trial design and methods". (opens in new tab)
- Identification and risk stratification of coronary disease by artificial intelligence-enabled ECG. (opens in new tab)
Triomics
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Anumana | Triomics |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Epic, OncoEMR, iKnowMed, Cerner |
| Founded | n/a | n/a |
| HQ | US | US |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.